Search results

1. ASCO 2025 preview – KRAS challengers assemble

   ASCO 2025 preview – KRAS challengers assemble … when their titles were revealed .   Selected ASCO 2025 regular presentations for small molecules …

   
    

   Madeleine Armstrong
    
   - 05/19/2026 - 19:49

2. ASCO 2025 preview – Kura looks similar to Syndax

   ASCO 2025 preview – Kura looks similar to Syndax … differentiation syndrome 13% 13% Source ASCO 2025 abstract Nov 2024 PR Regulatory status …

   
    

   Madeleine Armstrong
    
   - 05/19/2026 - 19:49

3. ASCO 2025 preview – patritumab hangs in the balance

   ASCO 2025 preview – patritumab hangs in the balance … rate, which was no worse than for 2mg/kg.   ASCO 2025 regular presentations covering selected ADCs …

   
    

   Jacob Plieth
    
   - 05/19/2026 - 19:49

4. Trodelvy trumps Datroway again

   … for PFS in Apr 2025; trend to OS improvement; full data at ASCO 2025 Tropion-Breast05 , data due 2026 …

   
    

   Madeleine Armstrong
    
   - 05/19/2026 - 19:49

5. ASCO 2025 preview – Merus tops Bicara

   ASCO 2025 preview – Merus tops Bicara … EGFR epitope 806 and IL13Rα2.   Selected ASCO 2025 regular presentations for biologicals, excluding …

   
    

   Jacob Plieth
    
   - 05/19/2026 - 19:49

6. ASCO 2025 preview – Itovebi strengthens its first-line claim

   ASCO 2025 preview – Itovebi strengthens its first-line … *recalculated from 15.0 months. Source: product labels & ASCO 2025.   Both drugs hit the wild-type and mutant …

   
    

   Madeleine Armstrong
    
   - 05/19/2026 - 19:49

7. AbbVie gets a cMet niche

   … in high cMet expressers at doses ≥2.4mg/kg); data due at ASCO 2025 in EGFRm non-sq NSCLC Notes: …

   
    

   Madeleine Armstrong
    
   - 05/19/2026 - 19:49

8. ASCO 2025 preview – late-breakers in focus

   ASCO 2025 preview – late-breakers in focus … the morning of their presentations.   Selected ASCO 2025 late-breakers Project Company/ies …

   
    

   Jacob Plieth
    
   - 05/19/2026 - 19:49